UltraTech Cement vs Ambuja Cements 2027: Why One Grew Q2 Profit 21% While the Other Fell 90%
- November 17, 2026
- Posted by: Lakshit Sharma
- Category: Market
| UltraTech Cement vs Ambuja Cements at a glance | UltraTech Cement | Ambuja Cements |
|---|---|---|
| Share price (16 Nov 2026) | Rs 12,270.00 | Rs 382.00 |
| Market cap | Rs 3,61,225 crore | Rs 95,044 crore |
| P/E ratio | 40.89 | 30.12 |
| Q2 FY27 net profit | Rs 1,501 crore | Rs 236.0 crore |
Quick Answer
UltraTech Cement vs Ambuja Cements compares the cement businesses of the Aditya Birla Group and the Adani Group, India’s two largest cement producers. In Q2 FY27, UltraTech grew revenue 18.3% to Rs 23,406 crore and net profit 21.3% to Rs 1,501 crore. Ambuja’s revenue slipped 1.9% to Rs 9,255 crore and net profit fell 89.9% to Rs 236 crore against an unusually high year-ago base. UltraTech trades at a P/E of 40.89 and Ambuja at 30.12.
UltraTech Cement vs Ambuja Cements in 2027 begins with a wide profit gap: in the September 2026 quarter, UltraTech grew net profit 21.3% while Ambuja’s fell 89.9%, even though both operate in the same market and face the same fuel and freight costs. The UltraTech Cement vs Ambuja Cements profit gap is partly a base effect and partly a margin story.
Both companies are central to India’s cement industry. UltraTech is a Sensex and Nifty 50 company valued at about Rs 3,61,225 crore, while Ambuja is valued at about Rs 95,044 crore. This UltraTech Cement vs Ambuja Cements guide covers their business models, valuation, Q2 FY27 results, 2027 drivers, risks and shareholding.
Click Here – Get Free Investment Predictions
UltraTech Cement vs Ambuja Cements: Company Overview
What UltraTech Cement Does
UltraTech Cement, part of the Aditya Birla Group, is India’s largest cement producer by capacity. It makes grey cement, white cement and ready-mix concrete and sells through a network of dealers and retail outlets across the country.
The company has grown through both new plants and acquisitions, and it continues to add capacity each year. Promoters hold 58.48%.
What Ambuja Cements Does
Ambuja Cements is the flagship cement company of the Adani Group, which acquired it from Holcim in 2022. Through Ambuja and its subsidiaries, the group has become India’s second-largest cement player.
Ambuja has expanded quickly through acquisitions of smaller cement makers and new capacity. Promoters hold 67.33% of the company.
How UltraTech Cement and Ambuja Cements Make Money
Cement companies earn by producing cement at large plants and selling it to builders, infrastructure contractors and individual home builders. Profit depends on cement prices, plant utilisation and the cost of power, fuel and freight.
UltraTech’s scale gives it cost advantages in logistics and procurement. Its revenue is more than twice Ambuja’s, and it spreads fixed costs over a much larger volume.
Ambuja’s model rests on integrating newly acquired plants and using group resources in coal, power and logistics to lower costs over time. In UltraTech Cement vs Ambuja Cements, the speed at which Ambuja turns acquisitions into steady margins is the key variable.
UltraTech Cement vs Ambuja Cements Valuation and Key Metrics
The UltraTech Cement vs Ambuja Cements data below uses the 16 November 2026 close and trailing twelve month ratios.
| UltraTech Cement vs Ambuja Cements metric | UltraTech Cement | Ambuja Cements |
|---|---|---|
| Share price (CMP) | Rs 12,270.00 | Rs 382.00 |
| 52-week high | Rs 13,110.00 | Rs 573.10 |
| 52-week low | Rs 10,325.00 | Rs 341.00 |
| Distance from 52-week high | -6.4% | -33.3% |
| Market capitalisation | Rs 3,61,225 crore | Rs 95,044 crore |
| P/E ratio (TTM) | 40.89 | 30.12 |
| Industry P/E | 36.71 | 36.71 |
| P/B ratio | 4.91 | 1.59 |
| Return on equity (ROE) | 11.96% | 5.10% |
| Debt to equity | 0.40 | 0.02 |
| Dividend yield | 1.96% | 0.52% |
| FY26 revenue | Rs 89,089 crore | Rs 41,490 crore |
| FY26 net profit | Rs 8,188 crore | Rs 5,637 crore |
The UltraTech Cement vs Ambuja Cements table shows UltraTech trading at a P/E of 40.89 and 4.91 times book, against 30.12 and 1.59 for Ambuja. The cement industry P/E is 36.71, so UltraTech trades above the sector and Ambuja below it.
UltraTech has a much higher return on equity at 11.96% against 5.10%. Ambuja’s large equity base, built up through capital raising for acquisitions, keeps its ROE low. Ambuja is almost debt-free, while UltraTech’s debt to equity is 0.40.
Ambuja’s share price of Rs 382 is about 33.3% below its 52-week high of Rs 573.10. UltraTech at Rs 12,270 is only about 6.4% below its high of Rs 13,110.
UltraTech Cement vs Ambuja Cements Q2 FY27 Results
Figures below are consolidated revenue and net profit for the quarter ended 30 September 2026.
| UltraTech Cement vs Ambuja Cements Q2 FY27 (Sep 2026 quarter) | UltraTech Cement | Ambuja Cements |
|---|---|---|
| Revenue Q2 FY27 | Rs 23,406 crore | Rs 9,255 crore |
| Revenue Q2 FY26 | Rs 19,781 crore | Rs 9,432 crore |
| Revenue change YoY | +18.3% | -1.9% |
| Net profit Q2 FY27 | Rs 1,501 crore | Rs 236.0 crore |
| Net profit Q2 FY26 | Rs 1,238 crore | Rs 2,336 crore |
| Net profit change YoY | +21.3% | -89.9% |
| Net profit Q1 FY27 | Rs 2,604 crore | Rs 660.0 crore |
In the Q2 FY27 results, UltraTech’s revenue rose 18.3% to Rs 23,406 crore and net profit rose 21.3% to Rs 1,501 crore. The September quarter is usually the weakest for cement due to monsoon rains, which is why profit was lower than the Rs 2,604 crore of Q1 FY27.
Ambuja’s revenue fell 1.9% to Rs 9,255 crore, and net profit fell 89.9% to Rs 236 crore. The year-ago profit of Rs 2,336 crore was far above its normal run-rate, as the June 2026 quarter profit of Rs 660 crore shows. Its operating margin also fell to 13.6% from 19.6%.
For UltraTech Cement vs Ambuja Cements, part of the gap is a base effect, but the margin decline at Ambuja is real and needs watching.
UltraTech Cement vs Ambuja Cements Profit Gap: 2027 Drivers
UltraTech: scale and steady expansion
UltraTech’s 2027 outlook rests on adding capacity in step with demand and using its scale to keep costs low. Its FY26 revenue grew about 16% to Rs 89,089 crore and net profit about 36% to Rs 8,188 crore.
Government spending on roads, railways and housing is the main demand driver. UltraTech’s national reach lets it serve this demand in every region.
Ambuja: turning acquisitions into margins
Ambuja’s FY26 net profit was Rs 5,637 crore on revenue of Rs 41,490 crore. Its challenge in 2027 is bringing acquired plants up to group efficiency and restoring its operating margin toward earlier levels.
In the UltraTech Cement vs Ambuja Cements profit gap, Ambuja would need several quarters of steady margins to close the distance with UltraTech. Its low P/B of 1.59 means the market is not paying much for this potential yet.
Sector factors
Cement prices, fuel costs and monsoon timing affect both companies. Industry consolidation, led by these two groups, may support pricing over time. Both are sensitive to any slowdown in infrastructure spending.
Compare cement stocks on the Univest Screener
Risks in UltraTech Cement vs Ambuja Cements
Risks for UltraTech Cement
UltraTech’s main risk is valuation. A P/E of 40.89 assumes steady growth, so a slowdown in demand or a fall in cement prices could hurt. Its debt to equity of 0.40 is higher than Ambuja’s due to acquisitions and expansion.
Risks for Ambuja Cements
In the UltraTech Cement vs Ambuja Cements risk check, Ambuja’s risks include its falling operating margin and the challenge of integrating several acquired businesses. Its stock is about 33% below its 52-week high, showing weak sentiment. Group-level news can also move the stock.
UltraTech Cement vs Ambuja Cements Shareholding
| UltraTech Cement vs Ambuja Cements shareholding (Sep ’26, change vs a year earlier or nearest quarter) | UltraTech Cement | Ambuja Cements |
|---|---|---|
| Promoters | 58.48% (-0.75 pts vs Sep ’25) | 67.33% (-0.35 pts vs Dec ’25) |
| Foreign institutions (FII) | 12.69% (-3.13 pts vs Sep ’25) | 5.66% (-0.14 pts vs Dec ’25) |
| Domestic institutions (DII) | 20.86% (+4.21 pts vs Sep ’25) | 19.35% (-0.50 pts vs Dec ’25) |
| Public and others | 7.97% (-0.33 pts vs Sep ’25) | 7.66% (+0.99 pts vs Dec ’25) |
UltraTech promoters hold 58.48%, down from 59.23%. Domestic institutions raised their stake from 16.65% to 20.86%, while foreign institutions cut theirs to 12.69%.
Ambuja promoters hold 67.33%, against 67.68% in December 2025. Domestic institutions hold 19.35% and foreign institutions 5.66%. In UltraTech Cement vs Ambuja Cements, domestic funds are the bigger institutional holders in both companies.
Download the Univest iOS App or Univest Android App to track UltraTech Cement and Ambuja Cements live and follow cement sector research.
Which Investor Does Each Cement Stock Suit?
UltraTech Cement suits investors who prefer the market leader
Within UltraTech Cement vs Ambuja Cements, UltraTech fits investors who want the largest cement company, steady growth and a strong record of execution. They need to accept a P/E above the industry average.
Ambuja Cements suits investors looking for a recovery
Ambuja fits investors who want exposure to a fast-growing cement group at a low P/B and a share price well below its high. They need patience while margins and integration improve.
Final View on UltraTech Cement vs Ambuja Cements
UltraTech Cement vs Ambuja Cements pairs the market leader with the fastest-consolidating challenger. UltraTech grew Q2 FY27 profit 21.3% and trades at 40.89 times earnings. Ambuja’s profit fell 89.9% against a high base, and its margin dropped to 13.6%.
The UltraTech Cement vs Ambuja Cements profit gap will narrow only if Ambuja’s margins recover through 2027. Investors should watch cement prices, cost trends and the progress of Ambuja’s integration before forming a view.
Disclaimer: Data and figures in this article are drawn from publicly available information and company disclosures, and they may change after publication. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on UltraTech Cement vs Ambuja Cements
Why did Ambuja Cements' profit fall 90% in Q2 FY27?
Ans. Ambuja's net profit fell 89.9% to Rs 236 crore in Q2 FY27 from Rs 2,336 crore a year earlier. The year-ago figure was far above its normal quarterly level, so part of the fall is a base effect. Its operating margin also fell to 13.6% from 19.6%. Revenue slipped 1.9% to Rs 9,255 crore.
How did UltraTech Cement perform in Q2 FY27?
Ans. UltraTech's revenue rose 18.3% to Rs 23,406 crore and net profit rose 21.3% to Rs 1,501 crore in Q2 FY27. Profit was lower than Q1 FY27 because the monsoon quarter is seasonally weak for cement. Its operating margin was 16.4%. The company remains the largest cement maker in India.
Which cement stock has the lower P/E?
Ans. Ambuja Cements trades at a P/E of 30.12, while UltraTech Cement trades at 40.89. The cement industry P/E is 36.71. Ambuja also trades at a P/B of 1.59 against 4.91 for UltraTech. A lower multiple reflects weaker recent profitability.
What is the ROE of UltraTech and Ambuja?
Ans. UltraTech has a return on equity of 11.96%, while Ambuja's ROE is 5.10%. Ambuja's large equity base from capital raising keeps its ROE low. UltraTech earns more on its capital because of its scale. ROE helps compare how efficiently each company uses shareholder money.
Who owns UltraTech Cement and Ambuja Cements?
Ans. UltraTech is part of the Aditya Birla Group, with promoters holding 58.48%. Ambuja is part of the Adani Group, with promoters holding 67.33%. Domestic institutions hold 20.86% of UltraTech and 19.35% of Ambuja. Foreign institutions hold 12.69% and 5.66% respectively.
How far are the two stocks from their 52-week highs?
Ans. UltraTech closed at Rs 12,270 on 16 November 2026, about 6.4% below its 52-week high of Rs 13,110. Ambuja closed at Rs 382, about 33.3% below its high of Rs 573.10. Ambuja's 52-week low is Rs 341. Prices change daily.
Is UltraTech Cement vs Ambuja Cements a buy or sell decision?
Ans. This UltraTech Cement vs Ambuja Cements comparison is educational and does not give a buy or sell call. UltraTech offers scale and steady growth at a P/E of 40.89. Ambuja offers a recovery case at a P/B of 1.59 with weaker current margins. Investors should consult a SEBI-registered adviser before acting.